BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 32435895)

  • 21. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
    Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
    Front Immunol; 2022; 13():885307. PubMed ID: 35720325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis.
    Romick-Rosendale LE; Brunner HI; Bennett MR; Mina R; Nelson S; Petri M; Kiani A; Devarajan P; Kennedy MA
    Arthritis Res Ther; 2011; 13(6):R199. PubMed ID: 22152586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of Anti-Glomerular Basement Membrane Antibodies in 200 Patients With Systemic Lupus Erythematosus With or Without Lupus Nephritis: Results of the GOODLUPUS Study.
    Bourse Chalvon N; Orquevaux P; Giusti D; Gatouillat G; Tabary T; Tonye Libyh M; Chrusciel J; Drame M; Stockton-Bliard G; Amoura Z; Arnaud L; Lorenz HM; Blaison G; Bonnotte B; Magy-Bertrand N; Revuz S; Voll RE; Hinschberger O; Schwarting A; Pham BN; Martin T; Pennaforte JL; Servettaz A
    Front Immunol; 2020; 11():597863. PubMed ID: 33381119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations.
    Abdulahad DA; Westra J; Bijzet J; Dolff S; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Res Ther; 2012 Aug; 14(4):R184. PubMed ID: 22892043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.
    Faustini F; Idborg H; Fuzzi E; Larsson A; Lie WR; Pötzsch S; Okitsu SL; Svenungsson E; Gunnarsson I
    Lupus; 2023 Feb; 32(2):252-262. PubMed ID: 36508734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Laboratory and morphologic parameters in patients with lupus nephritis].
    Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of the 2019 EULAR/ACR systemic lupus erythematosus classification criteria in a cohort of patients with biopsy-confirmed lupus nephritis.
    Wang H; Gao Y; Ma Y; Cai F; Huang X; Lan L; Ren P; Wang Y; Chen J; Han F
    Lupus Sci Med; 2021 Feb; 8(1):. PubMed ID: 33558437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Albumin-to-globulin ratio (AGR) as a potential marker of predicting lupus nephritis in Chinese patients with systemic lupus erythematosus.
    Liu XR; Qi YY; Zhao YF; Cui Y; Wang XY; Zhao ZZ
    Lupus; 2021 Mar; 30(3):412-420. PubMed ID: 33407045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological aspects of biopsy-proven lupus nephritis in Bahraini patients with systemic lupus erythematosus.
    Farid EM; Hassan AB; Abalkhail AA; El-Agroudy AE; Arrayed SA; Al-Ghareeb SM
    Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1271-9. PubMed ID: 24231503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures.
    Wakasugi D; Gono T; Kawaguchi Y; Hara M; Koseki Y; Katsumata Y; Hanaoka M; Yamanaka H
    J Rheumatol; 2012 Jan; 39(1):79-85. PubMed ID: 22089455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical manifestations, immunological features and prognosis of Chinese pediatric systemic lupus erythematosus: A single-center study.
    Zhang CX; Cai L; Zhou ZY; Mao YY; Huang H; Yin L; Chen TX; Zhou W
    Int J Rheum Dis; 2019 Jun; 22(6):1070-1076. PubMed ID: 30957986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.
    Srivastava P; Abujam B; Misra R; Lawrence A; Agarwal V; Aggarwal A
    Lupus; 2016 Apr; 25(5):547-57. PubMed ID: 26637291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The outcome of patients with renal involvement in pediatric-onset systemic lupus erythematosus--a 20-year experience in Asia.
    Lee PY; Yeh KW; Yao TC; Lee WI; Lin YJ; Huang JL
    Lupus; 2013 Dec; 22(14):1534-40. PubMed ID: 23966304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
    Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
    Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validity of immunoglobulin-binding protein 1 as a biomarker for lupus nephritis.
    Ebaid AM; Ezzeldin N; Abdelhady EI; Mohammed HA; Abdallah AL
    Lupus; 2023 Jan; 32(1):101-110. PubMed ID: 36418233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Clinical Features, Treatment and Outcomes of Lupus Nephritis Between Patients With Late- and Early-Onset Systemic Lupus Erythematosus: A Controlled Study.
    Mongkolchaiarunya J; Wongthanee A; Kasitanon N; Louthrenoo W
    J Clin Med Res; 2024 Mar; 16(2-3):106-117. PubMed ID: 38550544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffuse proliferative glomerulonephritis does not determine the worst outcome in childhood-onset lupus nephritis: a 23-year experience in a single centre.
    Vachvanichsanong P; Dissaneewate P; McNeil E
    Nephrol Dial Transplant; 2009 Sep; 24(9):2729-34. PubMed ID: 19395731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric lupus nephritis - An evil cousin of its adult counterpart: A single-center based experience from a tertiary care hospital of Eastern India.
    Basu K; Karmakar S; Sengupta M; Roychowdhury A; Ghosh A; Bandopadhyay M
    Indian J Pathol Microbiol; 2020; 63(3):397-404. PubMed ID: 32769328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
    Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
    Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.